Global Consortium is finalizing a merger into BDCI. The Company has filed for a name and ticker change with FINRA.
The partners have hired a local company to supply the farmer with 24,640 industrial hemp clones at the cost of $5.00 per clone in 3 different strains to be planted on the test site. The farmer estimates two crop grows annually. If the initial test is proven, the next step is to plant up to 600 acres of hemp. If all 600 acres are planted, the estimated gross revenue expected to accrue annually is $120,000,000 minus $20,000,000 in operating expenses, resulting in a net of $100,000,000.
We are committed to the therapeutic value of cannabis oil to heal people while enjoying life. Our products are crafted, strain specific THC and CBD oils of premium quality.
Cannabis Consortium has designed three unique specialty item food delivery systems. Each system is patent-able. A different type of patented delivery system was used in a non-MJ sector application. The company marketing their device sold millions of units annually, and this proves a viable market exists for the products Cannabis Consortium has designed. The design of each of our delivery systems offers markedly different solutions to the specific technological problems, processes, and materials than the patented system. These major differences will allow us to file a series of patent applications that should be approved by the U.S. Patent and Trademark Office (USPTO). The usage applications for the delivery systems are flexible enough to appeal to both MJ and non-MJ sectors. This flexibility broadens the markets Cannabis Consortium can sell the device to since not all States have currently approved the use of marijuana for recreational or medical use, and not all buyers will need or want to be marijuana consumers. Cannabis Consortium will additionally apply for a series of Trademarks to USPTO to register and protect the brand names and logos, as applicable.
Cannabis Consortium plans to purchase rare 100% pure cocoa based derivatives such as powder, pastes, and chocolates. Cannabis Consortium has already established a relationship with a large farm located in the original home of the cocoa bean. The cocoa products we plan to sell are premier grade and very rare Nacional cacao bean types that when processed produce more mellow tasting and less acidic chocolate that lacks bitterness. The bean types are already scientifically tested for heritage, quality, and chemistry by a major global cocoa processor as part of the farmers ongoing in-country sales to the processor. As with our other specialty items we will market cocoa based derivative products to established Edible companies. Our direct relationship with the farmer gives us the ability to offer MJ cocoa consumers rare premium quality from-the-bean-to-the-table products. Edible companies we work with will be able chose the optimum format in which to then use the cocoa products they purchase from us to best enhance the flavor of their MJ products.
Using rare premium quality natural unsweetened cocoa powder, we plan to create MJ infused drinks in various MJ strengths and different flavors. While mixing chocolate and MJ into a drinking format is not a new concept, our ability to purchase 100% pure premier grade Nacional cacao beans will provide definitive advantages with respect to taste, quality, and marketability. As with our other specialty items we plan to partner with existing operations to create the best products in every location where sales are made. Our supplier has estimated to be able to begin supplying us with cocoa products by the end of the second quarter of 2018 subject to their export licensing and regulatory approval processes. Once the export-import channel has been established Cannabis Consortium will be able to market cocoa derivative products to its existing clients in the edible business. Cannabis should by this time have at least one (1) edible license and will be able to work the cocoa based products for consumer purchase in its own facility.
Sign up to hear from us.
One very important fact that was learned while trying to find a suitable merger candidate with an existing cannabis operation, was the companies all wanted some form of direct investment. While each of the companies had plenty of cashflow, they were only willing to part with a piece of equity rather than use any of their own cash on hand for further expansion. Based on the learning experience Cannabis Consortium plans to seek direct investments into private companies in return for an equity stake in the company. We are choosing to invest in private companies over public companies for two reasons: 1) with a private company we can establish a monthly share of the revenue prior to the investment, and 2) Public companies carry a greater risk of dilution since they rely solely on the equity component for repayment of investments. In the first six (6) months of 2017 Canada raised over $770 million for its cannabis companies alone.
Medical costs for family pets has risen to over $15 billion annually as of 2015 according to the American Pet Products Association. This number is expected to grow as more and more families recognize the family cat or dog as family member, and not just an animal. Baby boomers have also given rise to increased money spent on animal care. This includes $15.7 billion on vet care, $23 billion on food, $14.3 billion on supplies/OTC medicine and $5.2 billion on grooming and boarding. Cannabinoid oil has been proven to have multiple health benefits for humans. These same benefits can be used to treat the family cat or dog. Family pets can suffer from any ailment its human family can suffer from.
In 2005 researchers finished mapping the genome of the domestic dog, and the results proved that humans and dogs share a core set of DNA. Dogs suffer from more than 350 genetic disorders, many of which resemble human conditions. The most common diseases among purebred dogs include cancer, epilepsy, heart disease, allergies, retinal disease, and cataracts. Dogs have been used to test varying drug developments that have gone on to benefit humans already. Cannabis Consortium will work with holistic-minded Dr.’s to use Cannabinoid oils to treat cat and dogs. The process is one whereby Cannabis Consortium would supply the practitioners with the oils to treat the family pet and the Dr.’s would monitor the benefits through blood tests and x-rays. The end goal would be to find alternative treatments using Cannabinoids that could be shared with other vets in MJ friendly states to expand the benefits to as many cats and dogs as possible.
Please feel free to contact a member of our staff directly with any questions or comments you may have.
6810 N State Rd 7, Coconut Creek, FL 33073, US